Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Stock up 7 percent as ZEEL Board authorizes funding up to Rs 2000 Crore

    Stock up 7% as ZEEL Board authorizes funding up to Rs 2,000 Crore


    Finance Outlook India Team | Thursday, 06 June 2024

    The board of ZeeEntertainment Enterprises Limited (ZEEL) approved on Thursday the issue of equity shares or any other qualifying instruments (convertible or nonconvertible) through authorized means in one or more tranches, with the potential to generate up to Rs2,000 crore.

    "We wish to inform that the Board of Directors of the Company at its meeting held today has, inter-alia, considered and given its in-principle approval for raising funds by way of issuance of equity shares and/or any other eligible securities (convertible/nonconvertible) through permissible modes in one or more tranches, including but not limited to a private placement, a qualified institutions placement, preferential issue, or any other method or combination of methods, provided that the aggregate amount to be raised by issuance of such securities shall not exceed Rs 2,000 crore," the media firm stated.

    The choice needs to be approved by statutes and regulations, including the shareholders. "This will enable the company to enhance its strategic flexibility to pursue future growth opportunities in the evolving media landscape," stated ZEEL. The media company's shares increased 7.18% to a peak of Rs 157.55. At Rs 152.65, it was last seen trading up 3.84 percent.

    In comparison to the 100-day, 150-day, and 200-day simple moving averages (SMAs), the counter was trading lower than the 5-day, 10-, 20-, 30-day, and 50-day SMAs. The relative strength index (RSI) for the counter after 14 days was 55.20. Oversold is defined as a level below 30, while overbought is defined as a number beyond 70.

    The price-to-equity (P/E) ratio of the company's stock is 48.61, while the price-to-book (P/B) ratio is 1.47. The company's earnings per share (EPS) was 3.14, and its return on equity was 3.01.

    Approximately 23.16 lakh shares were traded today on the BSE. The amount exceeded the 14.66 lakh share two-week average volume. With a market capitalization (m-cap) of Rs 14,628.71 crore, the counter had turnover of Rs 35.64 crore. Promoters owned 3.99 percent of the corporation as of March 2024.



    Read More:

    Amazon Pay Enters Fixed Deposit Space With Up to 8% Returns

    Be Clinical Secures Seed Funding Led by V3 Ventures

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us